| COVID-19 vaccination in pregnancy, paediatrics, immunocompromised patients, and persons with history of allergy or prior SARS-CoV-2 infection: overview of current … N Luxi, A Giovanazzi, A Capuano, S Crisafulli, PM Cutroneo, MP Fantini, ... Drug safety 44 (12), 1247-1269, 2021 | 125 | 2021 |
| Allergic reactions to COVID-19 vaccines: risk factors, frequency, mechanisms and management N Luxi, A Giovanazzi, A Arcolaci, P Bonadonna, MA Crivellaro, ... BioDrugs 36 (4), 443-458, 2022 | 29 | 2022 |
| Cohort event monitoring of adverse reactions to COVID-19 vaccines in seven European Countries: pooled results on first dose M Raethke, F van Hunsel, NH Thurin, C Dureau-Pournin, D Mentzer, ... Drug Safety 46 (4), 391-404, 2023 | 5 | 2023 |
| Ilmiovaccino COVID19 collaborating group COVID-19 Vaccination in Pregnancy, Paediatrics, Immunocompromised Patients, and Persons with History of Allergy or Prior SARS-CoV-2 … N Luxi, A Giovanazzi, A Capuano, S Crisafulli, PM Cutroneo, MP Fantini, ... Drug Saf, 2021 | 5 | 2021 |
| Current practice in the measurement and interpretation of intervention adherence in randomised controlled trials: A systematic review A Giovanazzi, K Jones, RM Carr, CM Fairhurst, MR Backhouse, ... Contemporary Clinical Trials 118, 106788, 2022 | 4 | 2022 |
| Italian Guidelines for the Management of Sporadic Primary Hyperparathyroidism F Vescini, G Borretta, I Chiodini, M Boniardi, M Carotti, E Castellano, ... Endocrine, Metabolic & Immune Disorders Drug Targets 24 (8), 991, 2024 | | 2024 |
| Organisational models supported by technology for the management of diabetic disease and its complications in a diabetic clinic setting: study protocol for a randomised … A Giovanazzi, L Gios, M Mastellaro, MA Gentilini, F Valent, S Condini, ... Trials 24 (1), 513, 2023 | | 2023 |
| Covid-Vaccine-Monitor: a Cohort Event Monitoring Safety Study of COVID-19 Vaccines in Twelve European Countries F Riefolo, M Raethke, N Luxi, L Ruijs, A Giovanazzi, J Schmitz, D Mentzer, ... Drug Safety 45 (10), 1306-1307, 2022 | | 2022 |
